bg
A

Agios (AGIO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Agios (AGIO)

Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more

  • USD28.14
  • USD28.77
  • USD27.72
  • USD62.58
  • 9.00%
  • 37M
  • 120.00
  • 535.43k
  • 1.7B
  • 23.42
  • -14.00%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.